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Purpose. Congenital anomalies and injuries of the hand are often undertreated in low-middle income countries (LMICs).
Humanitarian missions to LMICs are commonplace, but few exclusively hand surgery missions have been reported and none have
attempted to demonstrate their cost-effectiveness. We present the first study evaluating the cost-effectiveness of a humanitarian
hand surgery mission to Honduras as a method of reducing the global burden of surgically treatable disease. Methods.D a t aw e r e
collectedfromahandsurgerymissiontoSanPedroSula,Honduras.Costswereestimatedforlocalandvolunteerservices.Thetotal
burden of disease averted from patients receiving surgical reconstruction was derived using the previously described disability-
adjusted life years (DALYs) system. Results. After adjusting for likelihood of disability associated with the diagnosis and likelihood
of the surgery’s success, DALYs averted totaled 104.6. The total cost for the mission was $45,779 (USD). The cost per DALY averted
was calculated to be $437.80 (USD), which is significantly below the accepted threshold of two times the per capita gross national
income of Honduras. Conclusions. This hand surgery humanitarian mission trip to Honduras was found to be cost-effective. This
model and analysis should help in guiding healthcare professionals to organize future plastic surgery humanitarian missions.
1. Introduction
Humanitarian missions to low-middle income countries
( L M I C s )h a v eb e c o m eam a j o rs o u r c eo fm e d i c a lc a r e
for underserved populations, particularly in plastic surgery.
Teams consist of a variety of healthcare professionals who
travel to the country in need, with all required supplies
andequipment.Onlocation,surgeonsperformlife-changing
procedures for patients with congenital deformities, trauma,
or burns, all of which cause significant disease burden on
the local population [1, 2]. This service is provided free of
charge to the patients. All expenses are paid by charitable
donations, usually without religious, financial, cultural, or
political agendas [3].
HondurasisademocraticnationinCentralAmericawith
ap o p u l a t i o no fa p p r o x i m a t e l y7 . 5m i l l i o n .O v e rh a l fo ft h e
populationlivesbelowthepovertylineandanestimated30%
a r eu n e m p l o y e d[ 4]. Like many LMICs, Honduras lacks both
resources and an adequate health care infrastructure to pro-
vide the care for its citizens. According to the World Health
Organization, “roughly 30.1% of the population receives no
healthcare,83%areuninsured,andthereismarkedexclusion
of ethnic minorities and rural populations.” Further, there
are only 8.8 physicians and 3 nurses per 10,000 citizens,
compared to 26 physicians and 94 nurses per 10,000 in the
United States [5]. In 2005, the per capita total expenditure on
healthcare in Honduras was $91 versus $6,350 in the United
States [4]. Furthermore, patients’ access to hospitals can be
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limitedgeographicallyandbyalackoftransportationmeans.
Atthesametime,medicaltechnologyandsurgicaltechniques
in developed countries continue to advance rapidly. This has
created a growing dichotomy in healthcare between rich and
poor countries [6, 7]. In particular, areas of subspecialty
surgery, such as reconstructive plastic surgery and hand
surgery, which are increasingly specialized in countries like
t h eU n i t e dS t a t e s ,a r ea l lb u ta b s e n ti ns o m ed e v e l o p i n g
nations [8, 9]. Because of this, humanitarian missions to the
developing world are becoming more and more relevant as
a way to provide direct aid and training to local surgeons.
Many medical and surgical mission trips throughout the
worldhavebeenreportedintheliteraturewithplasticsurgery
volunteertripsbeingespecially common,andthemajorityof
which involve cleft lip and palate repair [10]. Some reported
mission trips involve treatment of both hand anomalies
and craniofacial defects. However, very few of the reported
h u m a n i t a r i a nm i s s i o nt r i p sh a v ef o c u s e ds o l e l yo nh a n d
surgery. Further, the cost-effectiveness of such trips has not
been previously reported. In the present paper, we present a
report on the cost-effectiveness of a mission tripto Honduras
i nM a y2 0 0 6t h a te x c l u s i v e l yf o c u s e do nh a n ds u r g e ry .
2. Methods
2.1. Study Population. In May 2006, our group of 20 health-
care professionals traveled to San Pedro Sula, Honduras.
Our local sponsor, the Ruth Paz Foundation, a nonprofit
charitable group, assisted on site with organization, logistics,
a n da d v e r t i s i n g .W ew o r k e do u to fal o c a lp u b l i ch o s p i t a l
called Leonardo Martinez, which hosts a variety of medical
and surgical humanitarian mission trips. Team personnel
consisted of 3 hand/microsurgery trained surgeons, 1 plastic
surgerytrainedsurgeon,1hand/microsurgeryfellow,1plastic
surgery resident, 3 anesthesiologists, 1 pediatrician, 1 nurse
anesthetist,5operatingroomnurses,1recoveryroomnurse,1
hand therapist, 1 team administrator, and 1 photographer. All
surgical supplies (including gowns, drapes, sponges, sutures,
dressings,andplaster)andsurgicalinstrumentswerebrought
with the team for the trip.
MembersoftheRuthPazFoundationsetupthescreening
clinic and organized the follow-up visits. Potential patients
were alerted about the available services, through radio
announcements and fliers. The majority of the patients were
screenedforsurgeryontheprimaryscreeningdaywithaddi-
tional patients, who missed the main screening day, screened
each day. The operating schedule for the next five days was
createdbasedonthepatientsseenonthemainscreeningday.
Those screened for surgery were then immediately referred
to waiting anesthesiologists and pediatrician for same day
m e d i c a lc l e a r a n c e .P a t i e n t sw e r et h e ni n s t r u c t e dw h e nt o
return for surgery before they left.
Many minor procedures were performed with local
surgeons present in order to provide training for their
future practice. Ganglion cysts and masses were removed
for extreme size, intractable pain, or functional limitation.
Because of the team’s yearly trip to Honduras, we were
also able to perform more complex two-staged procedures.
All surgeries were performed by either a board certified
plastic surgeon or orthopedic surgeon. Each day, the team
would round on all postoperative patients in the morning
andintheevening.Thepatientswereseeninfollow-upclinic
by local physicians, who removed splints, dressings, sutures,
and k-wires, as necessary. Patients were also seen by local
physical and occupational therapists that provided assistance
w i t hs p l i n t sa sw e l la st h e r a p y .
2.2. Costs. The team’s costs for the trip were calculated by
addingtheteam’stravelexpenses,whichincludedtransporta-
tion, lodging, and donated supplies that were brought with
them (Table 1(a)). The team’s 2006 costs were then adjusted
for inflation to present day based on data obtained from
World Bank’s data [4].Weeklyhospitalpersonnelsalariesand
preoperative, intraoperative, and postoperative medication
costs were obtained from the Ruth Paz Foundation (Tables
1(b) and 1(c)). We were unable to obtain operative room cost
or daily hospital stay costs. Other fixed costs, such as utilities
and building costs, were not included as we were not able to
obtain thisinformation.Patientswere charged a symbolic fee
based on their household income by the local hospital for
services, but due to the nominal nature of the fee (ranging
from $0 to $50), this was not included for analysis.
2.3. Outcome. The total burden of musculoskeletal disease
was calculated for each patient that underwent surgery using
disability-adjusted life years (DALYs) format. As no surgery
performed was life-saving, all of the DALYs attributed were
from years lost to disability (YLD) and none from years
of life lost (YLL). YLD is calculated using disability weight
and the remaining life expectancy. In previous calculations
of YLD, age weighting factors and discount rate were also
incorporated in the calculation; however, the recently pub-
lished Global Burden of Disease 2010 study has moved away
from those adjustments [11]. Every patient’s diagnosis and
associated disability was matched as closely as possible to a
health state based on each state’s lay description as described
in Global Burden of Disease 2010 study. Each patient was
thenassignedadisabilityweightbasedontheclosestavailable
health state (Table 2). For each patient, the potential years
lived with disability value was calculated using the patient’s
age and life expectancy chart found in the Global Burden
of Disease 2010 study. For each patient, the DALY value
represents the burden of an untreated condition. This value
has been subsequently adjusted for likelihood of permanent
disability and likelihood of treatment success as described
i nt h el i t e r a t u r eb yM c C o r da n dC h o w d r ya n dm o d i fi e db y
Gosselinetal.[12–16] and represents the DALYs averted with
surgery (Table 3). To err on side of overestimating cost per
DALY averted, we chose conservative weights for disability,
likelihood of permanent disability, and effectiveness of treat-
ment. The scoring system used in assigning likelihood of
permanent disability and likelihood of treatment success is
shown in Table 4.Plastic Surgery International 3
Table 1: Mission costs.
(a) Team costs
Value (USD) in 2006 Cumulative inflation rate
( 2 0 0 6t o2 0 1 3 )
Inflation adjusted
value (USD) in 2013
%o ft o t a lc o s t s
Transportation and lodging $23,000 15.90% $26,650.34 62.2%
Donated supplies $14,000 15.90% $16,226.00 37.8%
Total cost $37,000 15.90% $42,876.34
(b) Local personnel salary
Weekly salary (USD) in 2013 Number Weekly cost (USD) % of total costs
Local surgeon $345 2 $690 45.3%
Surgical tech. $185 2 $370 24.3%
Nurse $185 2 $370 24.3%
Cleaning $92 1 $92 6.0%
Total cost $1,522
(c) Hospital costs
Weekly cost (USD) in 2013
Pre- and postoperative medications $448.84
Intraoperative medications $932
Total costs $1,380.84
(d) Overall mission cost
Cost (USD) % of total costs
Team costs $42,876.34 93.7%
Local personnel costs $1,522.00 3.3%
Hospital costs $1,380.84 3.0%
Total overall costs $45,779.18
(e) Cost-effectiveness metrics
If 2 × TC (i.e., doubled) If 5 × TC
Total cost (TC) $45,779.18 $91,558.36 $228,895.90
Cost per patient $572.24 $1,144.48 $2,861.20
Cost per DALY averted $437.80 $875.32 $2,188.30
∗
∗Still below $3,890 (2 × PCGNI)
∗PCGNI: per capita gross national income.
3. Results
I nt o t a l ,1 2 0p a t i e n t sw e r es c r e e n e da n d8 0p a t i e n t sw e r e
found to be candidates for surgery. Over the week, 128
total procedures were performed on 54 adults (68%) and 26
children (32%). The average age of the patient undergoing
surgery was 31 years with ages ranging from 10 months to 68
years. Of these patients, 27 were female (34%) and 53 were
male (66%). Table 4 includes the procedures performed on
each patient, as well as their age and gender. Operative time
for the entire trip totaled 93 hours and 50 minutes over 5
days. Average operative time was 18 hours and 46 minutes
per day and 6 hours and 15 minutes per operative table per
day. Most of the procedures were very short in duration, with
43 cases (53%) lasting less than 1 hour. 25 cases (31%) took
1-2 hours, 9 cases (11%) lasted 2-3 hours, and only 4 cases
(5%) were longer than 3 hours in duration. No immediate
complications,suchasischemiclossorearlywoundinfection,
were noted. There were no anesthetic complications and no
mortalities.
As shown in Table 4,t h et o t a ln u m b e ro fD A L Y sp o t e n -
tially avertable totaled 220.5. Adjusting for likelihood of
disability associated with the diagnosis and likelihood of the
surgery’s success, DALYs averted totaled 104.6. The total cost
(in current USD) for the volunteer trip including the team’s
travel and lodging cost of $45,779.18 and local hospital’s cost
of $2,903 (USD) is detailed in Table 1. On average, it costs
$572.24 (USD) per patient that was surgically treated. Cost-
effectivenesswasmeasuredusingcostperDALYavertedand,
for this trip, the cost for each DALY averted was conserva-
tively estimated to be $437.80 (USD), which is significantly
less than the accepted threshold of two times the per capita
gross national income of Honduras, $3,890 (USD). Further,
a brief sensitivity analysis provided in Table 1(e) displays that
eveniftotalcostsweretoincreaseby500%,thecostperDALY
averted would still be below the threshold of $3,890 (USD).4 Plastic Surgery International
Table 2: Patient characteristics.
Age Sex Diagnosis Available disability weight Disability weight
9F Tendon adhesion Musculoskeletal problems: arms, mild 0.024
16 M Finger flexor tendon injury Musculoskeletal problems: arms, mild 0.024
26 M Finger flexor tendon injury and nerve
laceration Injured nerves: long term 0.136
60 M Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
68 F Trigger finger Musculoskeletal problems: arms, mild 0.024
3F Finger flexor tendon injury Musculoskeletal problems: arms, mild 0.024
13 M Cubitus varus Disfigurement: level 1 0.013
14 M Polydactyly Disfigurement: level 1 0.013
47 M Lipoma Disfigurement: level 1, with itch or pain 0.029
57 F Trigger finger Musculoskeletal problems: arms, mild 0.024
11 M Burn scar contracture Burns of <20% total surface area or <10% total surface area if head or
neck or hands or wrist involved: long term, with or without treatment
0.018
12 M Burn scar contracture Musculoskeletal problems: arms, mild 0.024
21 F Partial traumatic amputation Amputation of finger(s), excluding thumb: long term, with treatment 0.03
30 F Nerve laceration Injured nerves: long term 0.136
34 M Skin contracture Musculoskeletal problems: arms, mild 0.024
47 M Radius and ulna fracture Fracture of radius or ulna: short term, with or without treatment 0.065
8M Metacarpal fracture Musculoskeletal problems: arms, mild 0.024
11 M Cubitus varus Disfigurement: level 1 0.013
21 M Burn scar contracture Burns of <20% total surface area or <10% total surface area if head or
neck or hands or wrist involved: long term, with or without treatment
0.018
45 M Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
48 M Carpal tunnel syndrome Injured nerves: short term 0.065
51 F Ganglion cyst Disfigurement: level 1, with itch or pain 0.029
67 M Dupuytren’s contracture Musculoskeletal problems: arms, moderate 0.114
5M Burn scar contracture Burns of <20% total surface area or <10% total surface area if head or
neck or hands or wrist involved: long term, with or without treatment
0.018
7M Polydactyly Disfigurement: level 1 0.013
19 F Tumor Disfigurement: level 1, with itch or pain 0.029
21 M Tumor Disfigurement: level 1, with itch or pain 0.029
31 M Dorsal ganglion cyst Disfigurement: level 1, with itch or pain 0.029
42 F Nonunion radius Fracture of radius or ulna: long term, without treatment 0.05
56 F De Quervain’s syndrome Musculoskeletal problems: arms, moderate 0.114
11mo M Thumb hypoplasia Amputation of thumb: long term 0.013
23 M Burn scar contracture Musculoskeletal problems: arms, mild 0.024
33 M Burn scar contracture Musculoskeletal problems: arms, moderate 0.114
37 F Hook nail deformity Disfigurement: level 1 0.013
48 M Dupuytren’s contracture Musculoskeletal problems: arms, mild 0.024
8M Flexor tendon injury Musculoskeletal problems: arms, mild 0.024
10 F Scar contracture Musculoskeletal problems: arms, mild 0.024
20 M Flexor tendon injury with nerve
laceration Injured nerves: long term 0.136
55 M Carpal tunnel syndrome Injured nerve: short term 0.065
5M Syndactyly Musculoskeletal problems: arms, mild 0.024
17 M Thumb hypoplasia Musculoskeletal problems: arms, moderate 0.114
18 M Foreign body with ulnar neuropathy Injured nerves: short term 0.065
23 M Foreign body Musculoskeletal problems: arms, mild 0.024
34 M Radial head fracture Fracture of radius or ulna: short term, with or without treatment 0.065Plastic Surgery International 5
Table 2: Continued.
Age Sex Diagnosis Available disability weight Disability weight
44 M Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
49 M Extensor tendon laceration Musculoskeletal problems: arms, mild 0.024
20 M Flexor tendon injury Musculoskeletal problems: arms, moderate 0.114
22 F Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
22 M Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
47 M Shoulder lipoma Disfigurement: level 1, with itch or pain 0.029
61 F Ganglion cyst and ulnocarpal
abutment Musculoskeletal problems: arms, moderate 0.114
5M Burn scar contracture Burns of <20% total surface area or <10% total surface area if head or
neck or hands or wrist involved: long term, with or without treatment
0.018
32 M Flexor tendon injury Musculoskeletal problems: arms, moderate 0.114
60 F Ganglion cyst Disfigurement: level 1, with itch or pain 0.029
61 M Finger flexor tendon injury Musculoskeletal problems: arms, moderate 0.114
65 F L ulna nonunion Fracture of radius or ulna: long term, without treatment 0.05
10 M Syndactyly Musculoskeletal problems: arms, mild 0.024
24 M Malunion Musculoskeletal problems: arms, moderate 0.114
35 F Nerve laceration Injured nerves: long term 0.136
38 M Nerve laceration Injured nerves: long term 0.136
10mo M L MF-RF syndactyly Musculoskeletal problems: arms, mild 0.024
17 M Malunion Fracture of hand: long term, without treatment 0.016
18 M Flexor tendon injury Musculoskeletal problems: arms, moderate 0.114
28 M Radial nerve laceration Injured nerves: long term 0.136
42 F Carpal tunnel syndrome Injured nerve: short term 0.065
14 M Flexor tendon injury with nerve
laceration Musculoskeletal problems: arms, moderate 0.114
23 F Burn scar contracture Burns of <20% total surface area or <10% total surface area if head or
neck or hands or wrist involved: long term, with or without treatment
0.018
50 M Radial nerve laceration Injured nerves: long term 0.136
9F Burn scar contracture Burns of <20% total surface area or <10% total surface area if head or
neck or hands or wrist involved: long term, with or without treatment
0.018
16 F Malunion Musculoskeletal problems: arms, mild 0.024
31 F Ganglion cyst Disfigurement: level 1, with itch or pain 0.029
47 F Ulnocarpal abutment Musculoskeletal problems: arms, moderate 0.114
55 F Carpal tunnel syndrome Injured nerve: short term 0.065
14 F Burn scar contracture Musculoskeletal problems: arms, moderate 0.114
39 F Ganglion cyst Disfigurement: level 1, with itch or pain 0.029
42 M Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
46 M Posttraumatic joint contracture Musculoskeletal problems: arms, mild 0.024
57 F Carpal tunnel syndrome Injured nerve: short term 0.065
23 M Finger mass Disfigurement: level 1, with itch or pain 0.029
62 M Skin lesion Disfigurement: level 1, with itch or pain 0.029
4. Discussion
Th i ss t u d yd e m o n s t r a t e st h a th a n ds u r g e r ym i s s i o nt r i p s
are a cost-effective means of providing surgical care at
HNQCP in San Pedro Sula, Honduras, using an established
economic evaluation model. We also inherently validate the
effectiveness of the DALY system as a useful and versatile
method of evaluating surgical mission trips. While it is one
of the first quantitative systems of evaluating such trips, it is
also only one of the many possible ways to analyze mission
trips. However, this analysis also represents an important
step in standardizing the evaluation of such trips to better
optimize foreign intervention by surgical teams, as proposed
by McCord [13].
The $437.80 per DALY averted for this week long sur-
gical mission trip is similar to those previously reported in6 Plastic Surgery International
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Table 4: Scoring system.
Weight
Likelihood of permanent disability
>9 5 %g oo nt od i s a b i l i t y 1 . 0
<95 and >50% 0.7
<50 and >5% 0.3
<5% 0
Effectiveness of treatment
>95% chance for cure 1.0
<95 and >50% 0.7
<50 and >5% 0.3
<5% 0
the literature that have ranged between $343 and $362 per
DALY [14, 15]. Our cost per DALY is well within the two
times per capita gross national income, an accepted metric
for program cost-effectiveness as suggested by earlier studies
[15]. We believe our slightly higher cost per DALY averted
can be attributed to multiple factors. First, we have used
conservative estimations for all DALY and disability weight.
Second, previous studies did not use the 2010 version of the
Global Burden of Disease (GBD) system to evaluate cost-
effectiveness and consequently may have contributed to dif-
ferences in the cost per DALY averted value. Third, bringing
more staff, such as residents, anesthesiologists/anesthetist,
pediatrician, nurses, and hand therapist, may have added to
travel and lodging cost. As the availability of more locally
trained medical professionals is available in Honduras, fewer
anesthesiologists, or nurses, and therapists from the United
States will be needed for each trip thus making each sub-
sequent mission trip more cost-effective than the previous.
With local capacity to care for simple cases like ganglion cyst
removal, trigger finger release, and arthrodesis, subsequent
tripscanfocusonmoredisablingcomplexconditionssuchas
nerve injuries which require advance surgical training. Since
a volunteer mission trip’s costs are relatively fixed, focusing
on these conditions can contribute to more DALYs averted
lowering the trip’s cost per DALY averted.
In addition to providing direct care, our team has been
able to lecture at the medical school in San Pedro Sula and
invite local surgeons to come and learn how to manage sur-
g i c a lh a n dc a s e s .O u rn u r s e sa n dt h e r a p i s t sh a v ea l s ow o r k e d
with local staff to improve pre-, peri-, and postoperative care
of patients. Such training and educational efforts are often
difficulttoquantifyandarenotreflectedinthecostperD AL Y
averted,buttheyareimportantinthelong-termdevelopment
of adequately trained local health care professionals and
healthcareinfrastructure.Whilethecapacitytocareforthese
surgical conditions is being developed in Honduras, surgical
mission trips such as ours serve as an important bridge until
that day arrives.
The limitations of this study include the inability to
include certain costs, such as operating room, hospital stay,
utilities, and building costs; however, given the large margin
between the cost per DALY averted and the twice per capita
grossnationalincome(PCGNI) ofHonduras($3890in2012)
[4],webelievethattheunderreportedcostshaveonlyaminor
impactonthecostperDALYaverted.Eveniftotalcosts(TC)
were five times higher, the cost per DALY averted would still
b et h et h r e s h o l dv a l u eo f$ 3 8 9 0( 2
∗PCGNI), as illustrated in
Table 1(e). As in previous cost-effectiveness studies, a rough
trade-off is used to assign hand conditions with disability
weights as the Global Burden of Disease 2010 study does
not have many specific disability weights for various hand
conditions. There are also instances where disability weights
make little sense from a functional standpoint: amputation
of finger(s) excluding thumb has a disability weight of 0.030
w h i c hc o m p a r e sp o o r l yt od i s a b i l i t yw e i g h to f0 . 0 1 3f o r
amputation of thumb, long term. One can argue that the
loss of a thumb is more functionally debilitating than the
loss of a finger as opposition-apposition function is lost in a
thumbamputationandgripmaybeminimallyaffectedwitha
finger amputation [11]. The nature of short volunteer mission
trip makes obtaining long-term outcomes data difficult.
H o w ev e r ,w i thg r e a t e rc a p a c i t yi nh o s tc o u n t ri e s ,p r o s pe ct i v e
studies that assess patient outcomes will enable us to more
objectively determine patient outcomes without relying on
assumptions. Until then, we feel that using the correctional
factor “probability of successful treatment” is needed to
account for treatment success/failures as there is a lack of
f o l l o w - u pd a t a .I m p e r f e c ta si tm a y b e ,t h eD A L Ym e t h o df o r
assessing cost-effectiveness has been used in a number of
previous studies in LMICs and offers a more objective and
standardized way to assess the impact of surgical mission
trips, cost-effectiveness and serves as a benchmark for future
trips.
Conflict of Interests
The authors have no conflict of interests to report.
References
[1] P. Voche and P. Valenti, “Humanitarian surgery of the hand.
Our experience in Vietnam,” Annales de Chirurgie Plastique et
Esth´ etique,v o l .4 4 ,n o .1 ,p p .6 4 – 7 1 ,1 9 9 9 .
[2] M. Beveridge and A. Howard, “The burden of orthopaedic
disease in developing countries,” Journal of Bone and Joint
Surgery A,v o l .8 6 ,n o .8 ,p p .1 8 1 9 – 1 8 2 2 ,2 0 0 4 .
[3] C. N. Baran and Y. O. Tiftikcioglu, “Physicians for peace and
interplast Turkiye: combined humanitarian surgical activities
andconferences,”PlasticandReconstructiveSurgery,vol.119 ,no.
3 ,p p .1 0 7 7 – 1 0 9 0 ,2 0 0 7 .
[4] World Bank, http://www.worldbank.org/.
[5] World Health Organization, Honduras,2 0 1 3 ,http://www.who
.int/countries/hnd/en/.
[ 6 ] D .S .W a l s h ,“ Af r a m e w o r kf o rs h o r t - t e r mh u m a n i t a r i a nh e a l t h
care projects,” International Nursing Review,v o l .5 1 ,n o .1 ,p p .
23–26, 2004.
[7] S.BunyavanichandR.B.Walkup,“USpublichealthleadersshift
toward a new paradigm of global health,” The American Journal
of Public Health,v o l .9 1 ,n o .1 0 ,p p .1 5 5 6 – 1 5 5 8 ,2 0 0 1 .
[ 8 ] K .C .C h u n g,“ V o l u n t e e r i n gi nt h ed e v e l o p i n gw o r l d :t h e2 0 0 3 -
2004 sterling bunnell traveling fellowship to Honduras and
Cambodia,”Journal of Hand Surgery,v o l .29 ,no .6,p p .987 –99 3,
2004.12 Plastic Surgery International
[9] T. E. E. Goodacre, “Plastic surgery in a rural African hospital:
spectrum and implications,” A n n a l so ft h eR o y a lC o l l e g eo f
Surgeons of England,v o l .6 8 ,n o .1 ,p p .4 2 – 4 4 ,1 9 8 6 .
[ 1 0 ]V .K .L .Y e o w ,S .T .L e e ,T .J .L a m b r e c h te ta l . ,“ I n t e r n a t i o n a l
task force on volunteer cleft missions,” Journal of Craniofacial
Surgery,v o l .1 3 ,n o .1 ,p p .1 8 – 2 5 ,2 0 0 2 .
[11] C. J. Murray, T. Vos, R. Lozano et al., “Disability-adjusted life
years (DALYs) for 291 diseases and injuries in 21 regions, 1990–
2010: a systematic analysis for the Global Burden of Disease
Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2197–2223, 2010.
[12] C. McCord and Q. Chowdhury, “A cost effective small hospital
in Bangladesh: what it can mean for emergency obstetric care,”
InternationalJournalofGynecologyandObstetrics,v o l .8 1 ,n o .1 ,
p p .8 3 – 9 2 ,2 0 0 3 .
[13] C. McCord, “Volunteer orthopedic surgical trips in Nicaragua:
a cost-effectiveness evaluation,” World Journal of Surgery,v o l .
3 6 ,n o .1 2 ,p p .2 8 0 9 – 2 8 1 0 ,2 0 1 2 .
[14] R. A. Gosselin, G. Gialamas, and D. M. Atkin, “Comparing
the cost-effectiveness of short orthopedic missions in elective
and relief situations in developing countries,” World Journal of
Surgery,v o l .3 5 ,n o .5 ,p p .9 5 1 – 9 5 5 ,2 0 1 1 .
[15] A.T .Chen,A.P edtke,J .K.K obs,G.S.EdwardsJ r .,R.R.Cough-
lin, and R. A. Gosselin, “Volunteer orthopedic surgical trips
in Nicaragua: a cost-effectiveness evaluation,” World Journal of
Surgery,v o l .3 6 ,n o .1 2 ,p p .2 8 0 2 – 2 8 0 8 ,2 0 1 2 .
[16] R. Gosselin, D. Ozgediz, and D. Poenaru, “A square peg in a
round hole? Challenges with DALY-based “Burden of Disease”
calculations in surgery and a call for alternative metrics,” World
Journal of Surgery, vol. 37, no. 11, pp. 2507–2511, 2013.Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com